Publications by authors named "Lisa Modelevsky"

Claim this Profile
D
Defining the Rates of Cytokine Release Syndrome Associated With Talquetamab Step-up Doses.
Issam S Hamadeh, Lisa Modelevsky, Amelia Chan, Aaron Mitchell, Ross S Firestone

JCO Oncol Pract· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of methotrexate-refractory primary central nervous system lymphoma (PCNSL) at Memorial Sloan Kettering Cancer Center.
Seena Cherian, Lisa Modelevsky, Anne S Reiner, Christian Grommes

Leuk Lymphoma· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort.
Prakirthi Yerram, Samantha N Reiss, Lisa Modelevsky, Lauren Schaff, Anne S Reiner

Ann Lymphoma· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study.
Samantha N Reiss, Prakirthi Yerram, Lisa Modelevsky, Christian Grommes

Leuk Lymphoma· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City.
Prakirthi Yerram, Jennifer Thackray, Lisa R Modelevsky, Josiah D Land, Samantha N Reiss

J Oncol Pharm Pract· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas.
Prakirthi Yerram, Samantha N Reiss, Lisa Modelevsky, Igor T Gavrilovic, Thomas Kaley

J Neurooncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid infusion rituximab is well tolerated in patients with primary CNS lymphoma.
Lisa Modelevsky, Richard Tizon, Samantha N Reiss, Marcel Smith, Rachel Garonce

CNS Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas.
Samantha N Reiss, Prakirthi Yerram, Lisa Modelevsky, Christian Grommes

J Immunother Cancer· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis